The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients

International Journal of Colorectal Disease

Volumn 25, Issue 10, 2010, Pages 1177-1184

  Mroczko, Barbara ^a   Groblewska, Magdalena ^a   Okulczyk, Bogna ^a   Kędra, Bogusław ^a   Szmitkowski, MacIej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Colorectal adenoma; Colorectal cancer; MMP 9; TIMP 1; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CANCER SURVIVAL; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

EID: 77956185656     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-0991-9     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin (In press)
2. ER Fearon 1995 Molecular genetics of colorectal cancer Ann NY Acad Sci 768 101 110 10.1111/j.1749-6632.1995.tb12114.x 1:CAS:528:DyaK28XitV2isbc%3D 8526339
3. ER Fearon B Vogelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 759 767 10.1016/0092-8674(90)90186-I 1:CAS:528:DyaK3cXktlyhtrg%3D 2188735
4. P Vihinen VM Kahari 2002 Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer 99 157 166 10.1002/ijc.10329 1:CAS:528:DC%2BD38XivFyrsr4%3D 11979428
5. D Murray M Morrin S McDonnel 2004 Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism Anticancer Res 24 489 494 1:CAS:528:DC%2BD2cXkvVehu74%3D 15152948
6. TD Kim KS Song G Li, et al. 2006 Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer BMC Cancer 6 211 10.1186/1471-2407-6-211 16916471
7. NG Hurst DD Stocken S Wilson C Keh MJ Wakelam T Ismail 2007 Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients Br J Cancer 97 971 977 10.1038/sj.bjc.6603958 1:CAS:528:DC%2BD2sXhtFSnurbF 17912241
8. A Torii Y Kodera K Uesaka, et al. 1997 Plasma concentration of matrix metalloproteinase 9 in gastric cancer Br J Surg 84 133 136 10.1002/bjs. 1800840147 1:STN:280:DyaK2s7ps1aqtQ%3D%3D 9043478
9. S Ylisirnio M Hoyhtya T Turpeenniemi-Hujanen 2000 Serum matrix metalloproteinases-2, -9 and tissue inhibitors of metalloproteinases-1, -2 in lung cancer-TIMP-1 as prognostic marker Anticancer Res 20 1311 1316 1:CAS:528:DC%2BD3cXjtl2rtrY%3D 10810441
10. ZS Wu Q Wu JH Yang HQ Wang XD Ding F Yang XC Xu 2008 Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer Int J Cancer 122 2050 2056 10.1002/ijc.23337 1:CAS:528:DC%2BD1cXkt1ChsLg%3D 18172859
11. E Lambert E Dasse B Haye, et al. 2004 TIMPs as multifacial proteins Crit Rev Oncol Hematol 49 187 198 10.1016/j.critrevonc.2003.09.008 15036259
12. RE Hewitt KE Brown M Corcoran WG Stetler-Stevenson 2000 Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line J Pathol 192 455 459 10.1002/1096-9896(2000) 9999:9999<::AID-PATH777>3.0.CO;2-E 1:CAS:528:DC%2BD3cXptVWqtLc%3D 11113862
13. L Guedez WG Stetler-Stevenson L Wolff, et al. 1998 In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1 J Clin Invest 102 2002 2010 10.1172/JCI2881 1:CAS:528:DyaK1cXnvVertbc%3D 9835626
14. K McCarthy T Maguire G McGreal E McDermott N O'Higgins MJ Duffy 1999 High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer Int J Cancer 84 44 48 10.1002/(SICI)1097- 0215(19990219)84:1<44::AID-IJC9>3.0.CO;2-P 1:STN:280:DyaK1M7ktVOgsg%3D%3D 9988231
15. M Lein L Nowak K Jung, et al. 1999 Metalloproteinases and tissue inhibitors of matrix-metalloproteinases in plasma of patients with prostate cancer and in prostate cancer tissue Ann NY Acad Sci 878 544 546 10.1111/j.1749-6632.1999.tb07722.x 1:STN:280:DyaK1MzksVamtQ%3D%3D 10415768
16. A Oberg M Hoythya B Taveli R Stenling G Lindmark 2000 Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer Anticancer Res 20 1085 1091 1:CAS:528:DC%2BD3cXjtl2ku78%3D 10810401
17. H Ishida N Murata Y Hayashi M Tada D Hashimoto 2003 Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients Surg Today 33 885 892 10.1007/s00595-003-2628-x 1:CAS:528:DC%2BD3sXps1yhtLg%3D 14669077
18. MN Holten-Andersen RW Stephens HJ Nielsen, et al. 2000 High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer Clin Cancer Res 6 4292 4299 1:CAS:528:DC%2BD3cXovVSgur0%3D 11106246
19. N Yukawa T Yoshikawa M Akaike, et al. 2004 Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer Anticancer Res 24 2101 2105 1:CAS:528:DC%2BD2cXmsV2isrw%3D 15274408
20. N Yukawa T Yoshikawa M Akaike, et al. 2007 Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer Oncology 72 205 208 10.1159/000112827 1:CAS:528: DC%2BD1cXptlKksA%3D%3D 18160809
21. ET Waas T Hendriks RM Lomme T Wobbes 2005 Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients Dis Colon Rectum 48 700 710 10.1007/s10350-004-0854-y 15906450
22. L Herszényi F Sipos O Galamb, et al. 2008 Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia- adenocarcinoma sequence of the colon Pathol Oncol Res 14 31 37 10.1007/s12253-008-9004-5 18347934
23. T Tomita K Iwata 1996 Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas Dis Colon Rectum 39 1255 1264 10.1007/BF02055119 1:STN:280:DyaK2s%2Fns1Wiug%3D%3D 8918435
24. NB Liabakk I Talbot RA Smith K Wilkinson F Balkwill 1996 Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer Cancer Res 56 190 196 1:CAS:528: DyaK28Xit1CgsQ%3D%3D 8548762
25. Jass JR, Sobin LH (1989) WHO international histological classification of tumors. Histological typing of intestinal tumors. Springer-Verlag, New York
26. B Mroczko M Szmitkowski B Okulczyk 2003 Hematopoietic growth factors in colorectal cancer patients Clin Chem Lab Med 41 646 651 10.1515/CCLM.2003.098 1:CAS:528:DC%2BD3sXksFGmsrY%3D 12812262
27. H Sato Y Kida M Mai, et al. 1992 Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells Oncogene 7 77 83 1:CAS:528:DyaK38XhvFWrt7w%3D 1311064
28. Y Ogata K Miura A Ohkita H Nagase K Shirouzu 2001 Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma Kurume Med J 48 211 218 1:CAS:528:DC%2BD3MXpt12qs7w%3D 11680936
29. AZ Gimeno-García A Santana-Rodríguez A Jiménez, et al. 2006 Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence Eur J Cancer 42 3246 3252 10.1016/j.ejca.2006.06.025 16973348
30. MN Holten-Andersen C Fenger HJ Nielsen, et al. 2004 Plasma TIMP-1 in patients with colorectal adenomas: a prospective study Eur J Cancer 40 2159 2164 10.1016/j.ejca.2004.06.011 1:CAS:528:DC%2BD2cXntlGhu7o%3D 15341992
31. M Groblewska B Mroczko U Wereszczyńska-Siemia̧tkowska, et al. 2008 Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients Clin Chem Lab Med 46 1423 1428 10.1515/CCLM.2008.278 1:CAS:528:DC%2BD1cXhtlOqtrfE 18844497